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Carcinogenicity of By-Products of
Disinfection in Mouse and Rat Liver
by Sydna L. Herren-Freund* and Michael A. Pereira*
By-products ofdisinfection were tested for initiating and/or promoting activity in rat liver by using the
rat liver foci bioassay. The assay uses an increased incidence of -y-glutamyltranspeptidase-positive foci
(GGT foci) as an indicator of carcinogenicity. The by-products of disinfection, including chloramine,
halogenated humic acids, halogenated ethanes, halogenated acetonitriles, halogenated methanes, halo-
genated ethylenes, and N-Cl-piperidine, did not initiate GGT foci, which would indicate that they are not
capable of initiating carcinogenesis. Chloroform and halogenated benzenes were tested in this assay for
their ability to promote the occurrence of GGT foci and tumors initiated by diethylnitrosamine (DENA).
Chloroform (1800 ppm in the drinking water) either had no effect or inhibited the occurrence ofGGT foci
when administered subsequent to a single dose ofDENA. However, whenthe chloroform was administered
in drinking water concurrently with weekly doses of DENA, it enhanced the formation of liver tumors.
Of 20 halogenated benzenes tested, only 1,2,4,5-tetrachlorobenzene and hexachlorobenzene promoted the
occurrence of DENA-initiated GGT foci. Thus in rat liver, the tested by-products of drinking water dis-
infection did not demonstrate tumor-initiating activity, although a few appeared to possess tumor-pro-
moting activity.
Chloroform was also tested for tumor-promoting activity in 15-day-old Swiss mice initiated with ethyl-
nitrosourea (ENU). At weaning they started to receive either 1800 ppm chloroform or 500 ppm sodium
phenobarbital (the positive control for tumor promotion) in their drinking water. The mice continued to
receive either chloroform or phenobarbital until 51 weeks of age and were sacrificed at 52 weeks of age.
ENU at 5 and 20 ,ug/g caused adose-dependent increase in livertumors. In male mice, chloroform inhibited
both spontaneous and ENU-induced liver tumors. When administered in the drinking water, chloroform
inhibited, whereas phenobarbital promoted, hepatocarcinogenesis in mice.
Introduction
Experimental chemical carcinogenesis is generally
considered to be a multistage process consisting of at
least the stages of initiation and promotion. Initiation-
promotion was first observed in mouse skin, where an
increased yield of tumors resulted from repeated ap-
plications of croton oil to skin that had been previously
exposed to a single subcarcinogenic dose of
benzo(a)pyrene (1-3). Initiation-promotion has been de-
scribed in tissues other than skin, including liver, blad-
der, and stomach (4-9). Initiation occurs when a car-
cinogen binds to the DNA followed by fixation of the
alteration during cellular replication (10,11). The al-
tered genotype can be observed as an altered pheno-
type. Promotion is believed to result in clonalexpansion
ofthe initiated cell (12). This clonal expansion can occur
through direct stimulation of cellular replication of the
initiated cells orthrough indirect stimulation ofinitiated
cells as the result ofthe inhibition ofcellular replication
in the surrounding noninvolved cells. Clonal expansion
results in a focus of cells possessing the altered phen-
otype.
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An initiation-promotion bioassay called the rat liver
foci bioassay is beingdeveloped inrodent liverto detect
chemical carcinogens (13-16). The endpointofthe assay
is the occurrence ofaltered foci ofhepatocytes that are
putative preneoplastic lesions. The occurrence ofthese
altered foci depends on the administration of a carcin-
ogen or an initiator and can be enhanced by subsequent
administration of a promoter (15,16). These foci are
readily identified histochemically as focal areas with in-
creased y-glutamyltranspeptidase (GGT) activity, de-
creased adenosine triphosphatase activity, decreased
glucose-6-phosphatase activity, or a resistance to iron
accumulation in sideroticliver. Theinitiation-promotion
bioassay using GGT-foci has detected the initiating ac-
tivity of both hepatic and nonhepatic carcinogens (17).
It has also detected the promoting activity ofchemicals
such as barbital (18), hexachlorobenzene (19), lindane
(19), mestranol (20), phenobarbital (18-27), polychlo-
rinated biphenyls (22,23,28) and 2,3,7,8-tetrachlorodi-
benzo-p-dioxin (29). Thus we used this assay to assess
the initiating and promoting ability of drinking water
disinfection by-products.
The administration ofethylnitrosourea (ENU) to 15-
day-old mice has been shown to be an effective proce-
dure for initiating liver tumors (30,31), and the admin-HERREN-FREUND AND PEREIRA
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FIGURE 1. Protocol for the liver foci bioassay.
istration of phenobarbital has been shown to be an ef-
fective procedure for promoting mouse hepatocarcino-
genesis (31-34). The administration of chloroform in
corn oil by gavage induced livertumors in B6C3F1 mice
(35). Chloroform has been shown to lack or at most
possess minimum genotoxic activity (31,36-42) and has
also been shown to not bind significantly to liver or
kidney DNA in rats (43-45). These findings have led to
the proposal that the hepatocarcinogenicity of chloro-
form in mice results from a nongenotoxic mechanism
such as tumor promotion (45,46). We therefore at-
tempted to demonstrate the hepatic tumor-promoting
activity of chloroform in mice.
Materials and Methods
Animals
Male Sprague-Dawley (CD-1) rats, male Fischer 344
rats, and male Swiss (CD-1) mice were purchased from
Charles River Co. (Portage, MI). The animals were fed
Purina Laboratory Rodent Chow (Ralston Purina Co.,
St. Louis, Mo) and given drinking water ad libitum.
The animals weremaintained accordingtothe standards
set forth in The Guide for the Care and Use of Labo-
ratory Animals (46).
Chemicals
Diethylnitrosamine (DENA) was purchased from
Eastman Kodak Co. (Rochester, NY); sodium pheno-
barbital (U.S.P.) from either Mallinckrodt Inc. (St.
Louis, MO) orJ. T. Baker (Phillipsburg, NJ); optimum
cutting temperature compound and hematoxylin from
Fisher Scientific Co. (Pittsburg, PA); N-y-L-glutamyl-
Table 1. Carcinogens that exhibit tumor-initiating activity in
the rat liver foci bioassay used in our laboratory.
Carcinogen Reference
2-Acetylaminofluorene (17)
Aflatoxin B1 (17)
Benzo(a)pyrene (17)
7,12-Dimethylbenz(a)anthracene (17)
1,2-Dimethylhydrazine (17)
Ethyl carbamate (urethane) (17)
Methylmethane sulfate (55)
N-Methyl-N-nitro-N-nitrosoguanidine (17)
N-Methyl-N-nitrosourea (55)
N-Nitrosodiethylamine (16, 17)
N-Nitrosodimethylamine (17, 55)
4-methoxy-2-naphthylamide from Bachem (Torrance,
CA); ENU (purity >95%) fromSigmaChemical Co. (St.
Louis, MO); and chloroform (glass-distilled, nonpres-
ervative, and purity >99%) from Burdick and Jackson
Laboratories Inc. (Muskegon, MI).
Experimental Design
RatLiverFociBioassay. Unless otherwise stated,
these studies followed the protocol outlined in Figure
1. The rats were treated with the test compound 18 or
24hraftera%partialhepatectomy. Thepositivecontrol
for initiation was DENA. Seven days after initiation,
promotion by 500 ppm phenobarbital in the drinking
water was begun. After 10 weeks ofexposure to phen-
obarbital, the rats were removed from the exposure to
the promoter for 1 week and then sacrificed. At sacri-
fice, 10 x 10 x 2 mm blocks of liver tissue were re-
moved, frozen in optimum cutting temperature com-
pound, cut into 8-,um sections, and stained for the
presence ofGGT activity according to the procedure of
Rutenburg et al. (47). The sections were analyzed for
the incidence of GGT foci and other lesions.
When the ability of a chemical to promote hepato-
carcinogenesis was evaluated, DENA was used as the
initiator, and phenobarbital was used as the positive
control for promotion. Starting 1 week after the admin-
istration oftheDENA, thetestchemicalwasgivenover
a period of at least 8 to 10 weeks. In one study, pro-
motion was continued until 32 weeks, at which time
tumors were observed. As with studies in which the
initiating activity of drinking water disinfection by-
products were tested, the incidence of GGT foci and
other lesions was determined.
Tumor Promotion Assay of Chloroform in Mouse
Liver. The protocol for this experiment has been pre-
viously published (31). Briefly, 15-day-old mice were
administered byintraperitoneal (IP) injection either20,
5, or 0 pug ENU/gbody weight. Afterweaning (5 weeks
ofage), thepupsweredividedaccordingtosexandwere
randomly assigned to one ofthefollowinggroups: group
1, 20 ,ug ENU/g; group 2, 5 jig ENU/g; group 3, 0 ,ug
ENU/g; group 4, 20 jig ENU/g followed by 1800 ppm
chloroform; group 5, 5 ,ug ENU/gfollowed by 1800 ppm
chloroform; group 6, 0 ,ugENU/gfollowed by 1800 ppm
chloroform; group 7, 20 ,ugENU/gfollowed by 500 ppm
sodium phenobarbital; group 8, 5 ,ug ENU/g followed
by 500 ppm sodium phenobarbital; and group 9, 0 ,ug
ENU/gfollowed by 500 ppm sodium phenobarbital. The
sodium phenobarbital and the chloroform were admin-
istered from weaning until the mice were 51 weeks old.
The mice were sacrificed at 52 weeks of age, and a
complete necropsy was conducted on each mouse.
Results and Discussion
The rat liver foci bioassay has been proposed for use
indeterminingwhetherachemicaloracomplexmixture
possesses tumor-initiating activity (16,48). The assay
has detected the tumor-initiating activity of69% ofthe
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Chemical
Halogenated methanes
Bromoform
Chloroform
Carbon tetrachloride
Halogenated ethanes
1,2-Dibromoethanes
1,1-Dichloroethane
1,2-Dichloroethane
Halogenated ethylenes
Tetrachloroethylene
Trichloroethylene
cis-1,2-dichloroethylene
trans-1,2-dichloroethylene
Vinylidene chloride
Halogenated acetonitriles
Table 2. Initiating activity of by-products of drinking water disinfection.a
Dose, mmole/kg Time after PH, hrb GGT foci/cm' (n)'
1.0
2.2
1.1
6.06
3.03
0.28
0.14
0.1
0.19
0.19
7.33
7.33
3.89
3.89
17.8
8.89
12.48
6.24
6.5
6.5
6.5
3.25
6.5
6.5
6.5
3.25
0.69
0.34
0.70
0.70
24
24
24
24
24
24
24
24
18
12
12
18
12
18
24
24
24
24
24
12
18
24
24
12
18
24
24
24
12
18
0.26 ± 0.10c
0.43 ± 0.15
0.59 ± 0.17
0.55 ± 0.19
0.63 ± 0.16
(9)
(9)
(8)
(10)
(9)
1.34 + 0.77
1.25 ± 0.25
1.09 ± 0.65
0.06 ± 0.04
0.00 ± 0.00
0.33 ± 0.01
0.54 ± 0.14
0.11 ± 0.08
0.20 ± 0.07
(2)
(7)
(10)
(10)
(8)
(10)
(10)
(10)
(10)
(8)
(10)
(10)
(9)
(10)
(9)
(10)
(10)
(10)
(9)
(10)
(9)
(10)
(9)
(9)
(10)
0.29 + 0.13
0.28 ± 0.11
0.21 ± 0.09
0.30 ± 0.16
0.50 ± 0.25
0.03 ± 0.03
0.17 ± 0.08
0.30 ± 0.09
0.53 ± 0.15
0.08 ± 0.05
0.10 ± 0.10
0.35 t 0.13
0.74 t 0.28
0.91 ± 0.17
0.21 ± 0.09
0.12 ± 0.06
Dibromoacetonitrile 2.0 24 1.00 ± 0.29 (6)
Dichloroacetonitrile 2.0 24 0.20 ± 0.12 (5)
Monchloroacetonitrile 1.0 24 0.46 ± 0.20 (10)
Trichloroacetonitrile 1.0 24 0.00 ± 0.00 (7)
Halogenated humic acids 2 mL/rat, 24 0.04 ± 0.04 (10)
pH 6.5-7.5
Chloramine 14.75 mg/kg 24 0.23 ± 0.10 (9)
N-Cl-Piperidine 40 mg/kg 24 0.80 ± 0.32 (9)
40 mg/kg 18 0.43 ± 0.13 (9)
40 mg/kg 12 0.21 ± 0.11 (10)
Diethylnitrosamine 0.5 18 9.27 ± 1.31 (10)
Tricaprylin 2 mL/kg 18 0.17 ± 0.15 (10)
aThe protocol for the rat liver bioassay used to determine tumor initiating activity is presented in Fig. 1.
bThe time the animals are administered the test substance following a 2/3 partial hepatectomy (PH).
cThe results are expressed as the mean ± standard error of the mean.
dThe number of animals.
carcinogens tested, whereas none ofthe tested noncar-
cinogens were active in the assay (49). The only carcin-
ogens that were not detected in the assay for tumor-
initiating activity were either nongenotoxic or were
direct-acting carcinogens (7,49). Because initiating ac-
tivity in the rat liver foci bioassay depends on the gen-
otoxic activity ofthe test substance, the lack ofactivity
by nongenotoxic chemicals in the assay was not unex-
pected. Table 1 contains a list of the hepatic and non-
hepatic carcinogens that have been tested for tumor-
initiating activity in our laboratory using the protocol
of the experiments described in this report. All these
carcinogens exhibited tumor-inititating activity in the
rat liver foci bioassay. It is recognized that the rela-
tionship between carcinogenesis and GGTfociand other
altered foci used as endpoints in the assay has yet to
be proved. Even so, the ability of the rat liver foci
bioassay to distinguish carcinogens from noncarcino-
gens and to detect the initiating activity ofhepatic and
nonhepatic carcinogens makes it suitable for determin-
ing whether a chemical or a complex mixture possesses
tumor-initiating activity.
The results from the rat liver foci bioassay for the
initiating activity of drinking water disinfection by-
products are presented in Table 2. Ofall the chemicals
found in drinking water, including disinfection by-prod-
ucts that were tested for initiating activity, only 1,2-
dibromoethane when given 24 hr after a partial hepa-
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Table 3. Induction of GGT foci following short-term exposure to
chloroform or phenobarbital.'
DENA Promoter GGT foci/cm2 (n)
+ CHC13 0.11 ± 0.11 (6)
+ PB 2.12 ± 0.43 (10)
+ - 0.08 ± 0.08 (8)
CHC13 0.43 ± 0.14 (8)
PB 1.38 ± 0.26 (9)
0.05 ± 0.05 (9)
aThe protocol for the rat liver foci bioassay used is presented in
Fig. 1. The animals received a 2 partial hepatectomy followed 1 day
later by 0.3 mmole/kg DENA. Seven days later, they started to re-
ceiveeither 1800ppmchloroform or500ppmphenobarbitalindrinking
water for a total of 8 weeks. The animals were sacrificed at the ter-
mination of the exposure to the promoters.
bThe results are expressed as the mean ± standard error of the
mean.
cThe number of animals.
tectomy exhibited initiating activity. The initiating ac-
tivity of 1,2-dibromoethane was minimal in comparison
to the activity observed with the DENA (the positive
control). Milks et al. (50) observed in a similar rat liver
foci bioassay that 1,2-dibromoethane did not initiate
GGT foci. Our in vivo initiation-promotion bioassay re-
sults also conflict with a previous study by Hatch et al.
(51) in which chlorinated methanes and ethanes en-
hanced viral tramsformation ofSyrian hamster embryo
cells. Some of the chemicals tested were chloroform,
1,2-dichloroethane, and 1,1-dichloroethane. Although
the in vitro data indicate that some of the compounds
may enhance cell transformation and therefore possibly
carcinogenesis, the in vivo data indicate that they do
not initiate carcinogenesis. In conclusion, disinfection
by-products, withthepossible exceptionof1,2-dibromo-
ethane, did not induce GGT foci, which indicates that
they do not possess significant ability to initiate carcin-
ogenesis.
Chloroform administered in corn oil has been shown
to induce hepatocellular carcinomas in mice and epithe-
lial tumors in the kidney ofmale rats (35). The inability
of chloroform to bind significantly to liver and kidney
DNA (44-46) and its lack or very low level ofgenotox-
icity (31,36-43) has led to the proposal that the carcin-
ogenicity of chloroform results from a nongenotoxic
mechanism such as tumor promotion (45,46). Because
themechanismofcarcinogenicity (i.e., genotoxic ornon-
genotoxic) of a substance has major implications in in-
terspecies and low-dose extrapolation, we attempted to
demonstrate the nongenotoxic and tumor-promoting
mechanism for the carcinogenic activity of chloroform.
The ability ofchloroform (CHCl3) to promote the ap-
pearance ofGGT foci was evaluated inmale Fischer344
rats(Table3). Theratsreceived a %partialhepatectomy
1 day before being treated with DENA (0.3 mmole/kg
body weight [bw]); 7 days later these rats were started
on chloroform (1800 ppm) in drinking water. Phenobar-
bital (PB) (500 ppm) in drinking water was used as a
positive control. Exposure to the promoters was con-
tinuedfor8weeks, andtheanimals werethensacrificed.
Phenobarbital enhanced the incidence of GGT foci,
whereas chloroform did not alter the incidence of GGT
foci/cm2.
Chloroform was then tested in male Sprague-Dawley
rats for its ability to act as a cocarcinogen (Table 4).
Chloroform (1800 ppm in the drinking water) was given
concurrently with weekly doses of DENA (8.2 mg/kg
body weight). Concurrent administration of phenobar-
bital (500 ppm) with DENA was used as the positive
control. Treatment was continued for either 16 or 32
weeks, at which time the rats were sacrificed. At nei-
ther time point did co-administration of chloroform in-
crease the incidence ofGGT foci over the incidence ob-
served in animals that received only DENA or over the
level in animals that received only the water vehicle
control (Table 4). Phenobarbital did increase the inci-
dence of GGT foci when co-administered with DENA.
The concurrent administration of either chloroform or
phenobarbital with DENA did not affect the incidence
of animals with tumors or the number of tumors per
animal. Hence, phenobarbital greatly increased the in-
cidence ofGGT foci without alteringthe yield oftumors
induced by DENA. This finding indicates that a quan-
titative relationship between the incidence of GGT foci
and the incidence oftumors does not exist in all exper-
imental protocols. Thus, a substance under certain ex-
perimental situations can increase the incidence ofGGT
foci without altering the incidence of tumors.
The effect ofadministering chloroform subsequent to
ethylnitrosourea (ENU) initiation in neonatal mice was
investigated (31). Fifteen-day-old CD-1 Swiss mice re-
ceived IP injections of either 20, 5, or 0 ,ug/g ENU
dissolved in 1.0 M sodium acetate (pH 5.6). After wean-
Table 4. Foci and tumor incidence with concurrent administrat;on of chloroforma.
GGT-foci/cm2b Tumors (32 wks)b
16 wk 32 wk % Animals with No. of tumors per
DENA Co-carcinogen w w tumors animal
+ CHCl3 0.13 ± 0.08 (8) 2.76 ± 0.50 (12) 83 (12) 1.3 ± 0.33
- CHCl3 0.00 ± 0.00 (8) 0.00 ± 0.00 (12) 0 (12) 0.0 ± 0.0
+ Phenobarbital 3.65 ± 1.51 (6) 23.58 ± 3.10 (11) 60 (10) 1.4 _ 0.45
Phenobarbital 0.14 ± 0.09 (8) 0.34 ± 0.11 (12) 0 (12) 0.0 ± 0.0
+ 0.16 ± 0.10 (8) 3.08 ± 0.58 (10) 60 (9) 0.8 0.25
0.00 ± 0.00 (8) 0.03 ±_0.03 (12) 0 (12) 0.0 0.0
aThe rats received weekly doses of 8.2 mg/kg DENA concurrently with either 1800 ppm chloroform or 500 ppm sodium phenobarbital in
their drinking water. The animals were sacrificed at either 16 or 32 weeks after the start oftreatment (16 or 32 doses ofDENA, respectively).
bThe results are expressed as the mean ± standard error of the mean. The number of animals is in parentheses.
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Table 5. Effect of subsequent treatment with chloroform or phenobarbital on the incidence of liver tumors initiated by ENU in 15-
day-old male mice.
No. of
animals No. of No. of
with animals animals No. of
ENU altered with with Adenomas animals with Carcinomas
Group treatment, mg/kg N Body weight, gb foci areas tumorsa adenomasc per animalb carcinomasc per animalb
ENU
1 20 30 42.4 1.1 23 22C 22 3.13 ± 0.57 10 0.83 ±0.24
2 5 39 40.4 0.7 16 8 8 0.51 ± 0.20 2 0.10 ±0.08
3 0 37 45.5±0.7 3 2 2 0.19±0.14 2 0.08±0.06
ENU + 1800 ppm
chloroform
4 20 29 38.0±0.9 17 12t 12** 1.00± 0.31t 5* 0.21± 0.14t
5 5 25 37.3 ± 1.1 7 it 1** 0.04 ± 0.04t 0 0.00 ±0.00
6 0 23 38.0 ± 0.8* 0 0 0 0.00 ± 0.00 0 0.00 ±0.00
ENU + 500 ppm
phenobarbital
7 20 25 45.7 ± 1.0 21 24 22 2.12 ± 0.30 17t 2.48 ±0.4
8 5 36 41.9±1.7 14 17* 14 0.56±0.16 lot 0.42±0.1
9 0 30 43.2 ± 0.6 4 lit 6 0.27 ± 0.10 6 0.23 ±0.0
aIncludes the number of animals with adenoma and/or carcinomas.
bResults are mean ± standard error.
'The results expressed as number of animals with either tumors, adenomas, or carcinomas were analyzed by Fisher's exact test, and the
results expressed as adenomas/animal or carcinomas/animal were analyzed by Student's t-test. The results of the ENU + chloroform groups
and the ENU + phenobarbital groups were compared to the corresponding ENU group.
*p 0.10.
tp S 0.05.
tp S 0.01.
ing, the pups were separated into groups and began to weeks of age. In the liver, administration of ENU re-
receive either 1800 ppm chloroform or 500 ppm phen- sulted in a dose-related increase in altered foci/areas,
obarbital in drinking water. Phenobarbital was used as adenomas, and hepatocellular carcinomas in male mice
the positive control for tumorpromotion. The mice con- (Table 5). Treatment with phenobarbital (500ppm) sub-
tinued to receive either chloroform or phenobarbital in sequent to ENU initiation increased the total hepato-
their drinking water until they were sacrificed at 52 cellular carcinoma incidence in male mice (Table 5).
Table 6. Promoting activity of the halogenated benzenesa.
GGT foci/cm2b
Chemical Dose, mmole/kg Male Female
Chlorobenzene 1.0 0.67 ± 0.31 (5) 0.64 ± 0.18 (7)
o-Dichlorobenzene 1.0 0.20 ± 0.10 (8) 0.68 ± 0.35 (8)
m-Dichlorobenzene 1.0 0.00 ± 0.00 (8) 0.27 ± 0.21 (7)
1,2,3-Trichlorobenzene 1.0 0.54 ± 0.20 (7) 0.39 ± 0.39 (2)
1,3,5-Trichlorobenzene 1.0 0.61 ± 0.24 (9) 0.57 ± 0.28 (7)
1,2,4-Tetrachlorobenzene 1.0 0.09 ± 0.09 (10) 0.13 ± 0.09 (10)
1,2,3,4-Tetrachlorobenzene 0.5 0.17 ± 0.12 (8) 0.33 ± 0.26 (7)
1,2,3,5-Tetrachlorobenzene 1.0 0.00 ± 0.00 (10) 0.312 ± 0.19 (7)
1,2,4,5-Tetrachlorobenzene 0.25 1.20 ± 0.34 (10) 0.19 ± 0.19 (7)
Pentachlorobenzene 0.5 0.15 ± 0.08 (10) NDc
Hexachlorobenzene 1.0 1.51 ± 0.72 (10) 1.28 ± 0.41 (10)
Bromobenzene 1.0 0.36 ± 0.18 (3) 0.14 ± 0.16 (6)
o-Dibromobenzene 1.0 0.70 ± 0.36 (7) ND
m-Dibromobenzene 1.0 0.00 ± 0.00 (9) ND
p-Dibromobenzene 1.0 0.00 ± 0.00 (9) ND
1,4-Dibromobenzene 1.0 0.19 ± 0.19 (10) ND
1,2,4-Tribromobenzene 1.0 0.10 ± 0.07 (10) ND
1,3,5-Tribromobenzene 1.0 0.16 ± 0.10 (10) ND
1,2,4,5-Tetrabromobenzene 1.0 0.13 ± 0.09 (9) ND
Hexabromobenzene 0.5 0.26 ± 0.14 (9) ND
Tricaprylin 2 ml/kg 0.17 ± 0.15 (10) 0.58 ± 0.23 (10)
aThe rats were administered 0.5 mmole/kg DENA followed at 1 and 5 weeks with IP injection of the halogenated benzene. The animals
were sacrificed 2 weeks after the last dose ofthe halogenated benzene was administered.
bThe results are expressed as the mean ± standard error of the mean. The number of animals is in parentheses.
cNot done.
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Treatment with chloroform (1800 ppm) subsequent to
theENU administration decreasedtheincidenceofliver
tumors by approximately one-half. In mice not initiated
with ENU, chloroform did not induce altered foci/areas
and tumors. Our results demonstrate that instead of
promoting the development ofliver tumors initiated by
ENU administered to neonatal mice, chloroform inhib-
ited the formation of the tumors. These results are in
contrast to the NCI-NTP-sponsored bioassay in which
liver tumors were found followingthe administration of
chloroform in corn oil by stomach gavage (35). The ob-
served differences between the two studies might be
the result of the different strains of mice used or the
result of vehicle differences (corn oil versus drinking
water) (31). Thus the mechanism by which chloroform
administered in corn oil can induce hepatocarcinoge-
nesis in mice and by which it can inhibit hepatocarcin-
ogenesis in mice when administered in drinking water
is poorly understood. It is the conclusion ofour studies
that the proposed ability ofchloroform to act as atumor
promoter has still not been proven.
Hexachlorobenzene has been shown to be carcino-
genic in rodent liver (52-54). Similar to that of chlo-
roform, its carcinogenic activity has been proposed to
result from the nongenotoxic mechanism oftumor pro-
motion. Therefore, a series of halogenated benzenes,
includinghexachlorobenzene, weretested fortheirabil-
ity to enhance the incidence of DENA-initiated GGT
foci in male and female Sprague-Dawley rats (Table 6).
The rats were administered DENA by gavage (0.5
mmole/kg body weight). Groups often rats each were
then administered one of the various halogenated ben-
zenes by IP injection at 1 and 5 weeks after the admin-
istration of DENA. Two weeks after the final dose of
the halogenated benzene was administered, the rats
were sacrificed. Of the various halogenated benzenes
tested, only 1,2,4,5-tetrachlorobenzene and hexachlo-
robenzene enhanced the occurrence ofGGT foci in male
rats and only hexachlorobenzene enhanced the occur-
rence of GGT foci in female rats. These results would
indicate that 1,2,4,5-tetrachlorobenzene and hexachlo-
robenzene can promote tumor development in rats and
that the other halogenated benzenes either are not tu-
mor promoters in rat liver, are tumor promoters by
virtue of a mechanism independent of GGT foci, or are
tooweaktobe detectedbytheprotocol used. Validation
of the tumor-promoting activity of 1,2,4,5-tetrachloro-
benzene and hexachlorobenzene still requires that their
enhancement of the incidence of tumors initiated by
DENA be demonstrated.
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